Moderna Co-Founder Regains Billionaire Status as Shares Boost US Market
Moderna co-founder Robert Langer has become a billionaire again after the biotech giant announced favorable results from a late-stage trial of a cancer vaccine, causing shares to double in value and contributing to a rise in US stock markets.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)Sources
Moderna Co-Founder Robert Langer Is A Billionaire Again As Shares Double In Value
The biotech giant announced favorable results from a late-stage trial of a cancer vaccine.
By Ty Roush, Forbes Staff
Read full article →US stocks: US market rises as yields ease, Moderna lifts healthcare stocks
US stock markets enjoyed a boost as easing bond yields and a spike in Moderna shares contributed to a favorable trading environment. Despite the Federal Reserve's minutes highlighting inflation concerns and discussions on rate hikes, investors remained optimistic. The Treasury's announcement of liquidity support revitalized riskier assets, particularly in tech stocks, while the success of Moderna's cancer therapy trial uplifted the healthcare sector.
Read full article →
